CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Photonic Hyperthermia Synergizes with Immune-Activators to Augment Tumor-Localized Immunotherapy.
Photonic Hyperthermia Synergizes with Immune-Activators to Augment Tumor-Localized Immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
光热免疫治疗,即光热热疗与免疫治疗的结合,是一种非侵入性且理想的治疗策略,可解决传统光热消融在肿瘤治疗中的不足。然而,光热处理后T细胞激活不足是获得满意治疗效果的瓶颈。在本工作中,基于聚吡咯磁性纳米药物,经抗CD3和抗CD28单克隆抗体T细胞激活剂修饰,合理设计并构建了一种多功能纳米平台,该平台实现了稳健的近红外激光触发光热消融和持久的T细胞激活,通过重新激活TIL(肿瘤浸润淋巴细胞),在光热热疗后实现诊断成像引导的免疫抑制肿瘤微环境调控。凭借高效的免疫原性细胞死亡和树突状细胞成熟,结合T细胞激活,该纳米系统在体内显著抑制原发肿瘤、远隔肿瘤以及转移肿瘤,且副作用可忽略不计,通过建立长期记忆免疫反应,发挥抑制肿瘤复发和转移的特异性功能。
Photothermal immunotherapy, the combination of photothermal hyperthermia and immunotherapy, is a noninvasive and desirable therapeutic strategy to address the deficiency of traditional photothermal ablation for tumor treatment.
However, insufficient T-cell activation following photothermal treatment is a bottleneck to achieve satisfactory therapeutic effectiveness. In this work, a multifunctional nanoplatform is rationally designed and engineered on the basis of polypyrrole-based magnetic nanomedicine modified by T-cell activators of anti-CD3 and anti-CD28 monoclonal antibodies, which have achieved robust near infrared laser-triggered photothermal ablation and long-lasting T-cell activation, realizing diagnostic imaging-guided immunosuppressive tumor microenvironment regulation following photothermal hyperthermia by reinvigorating tumor-infiltrating lymphocytes.
By virtue of high-efficient immunogenic cell death and dendritic cell maturation combined with T-cell activation, this nanosystem markedly restrains primary and abscopal tumors as well as metastatic tumors with negligible side effects in vivo, exerting the specific function for suppressing tumor recurrence and metastasis by establishing a long-term memory immune response.
MEMBER ACCOUNT
登录成功会直接打开下一页。